Table 4. Significant prognostic factors in multivariate analyses.
| P-value | RR | 95% CI | |
|---|---|---|---|
|
(A) (included: localisation, grading, Laurén classification, signet ring cell cancer, clinical response, complications, surgical complications, ypTNM, R status, and histopathological regression) | |||
| Clinical responsea |
0.004 |
1.53 |
1.14–2.05 |
| Complicationsa |
0.001 |
0.70 |
0.57–0.87 |
| ypT categorya |
0.002 |
|
|
| ypT0 | 0.009 | 0.31 | 0.13–0.75 |
| ypT1 | 0.039 | 0.51 | 0.27–0.97 |
| ypT2 | <0.001 | 0.42 | 0.26–0.68 |
| ypT3 |
0.140 |
0.81 |
0.61–1.07 |
| ypN categorya |
<0.001 |
|
|
| ypN0 | <0.001 | 0.45 | 0.33–0.63 |
| ypN1 | 0.010 | 0.65 | 0.47–0.90 |
| ypN2 | 0.003 | 0.66 | 0.48–0.68 |
| M category |
<0.001 |
0.55 |
0.42–0.73 |
| R category |
0.014 |
|
|
| R0 | 0.018 | 0.55 | 0.34–0.91 |
| R1 |
0.240 |
0.75 |
0.47–1.21 |
|
(B) (clinical response excluded) (included: localisation, grading, Laurén classification, signet ring cell cancer, complications, surgical complications, ypTNM, R status, and histopathological regression) | |||
| Localisationa |
0.006 |
|
|
| Signet cell type cancera |
0.033 |
1.32 |
1.02–1.70 |
| Complicationsa |
0.004 |
0.73 |
0.58–0.90 |
| ypT categorya |
<0.001 |
|
|
| ypT0 | <0.001 | 0.19 | 0.08–0.47 |
| ypT1 | 0.006 | 0.39 | 0.20–0.76 |
| ypT2 | <0.001 | 0.38 | 0.23–0.64 |
| ypT3 |
0.075 |
0.73 |
0.52–1.03 |
| ypN categorya |
<0.001 |
|
|
| ypN0 | <0.001 | 0.40 | 0.29–0.56 |
| ypN1 | 0.001 | 0.57 | 0.41–0.79 |
| ypN2 |
<0.001 |
0.60 |
0.45–0.80 |
| M categorya |
<0.001 |
0.53 |
0.40–0.70 |
| R categorya |
0.009 |
|
|
| R0 | 0.004 | 0.48 | 0.29–0.79 |
| R1 |
0.041 |
0.60 |
0.37–0.98 |
|
(C) (clinical response+localisation excluded) (included: grading, Laurén classification, signet ring cell cancer, complications, surgical complications, ypTNM, R status, and histopathological regression) | |||
| Complicationsa |
<0.001 |
0.69 |
0.56–0.85 |
| ypT categorya |
<0.001 |
|
|
| ypT0 | 0.001 | 0.23 | 0.10–0.55 |
| ypT1 | 0.008 | 0.42 | 0.23–0.80 |
| ypT2 | <0.001 | 0.40 | 0.28–0.72 |
| ypT3 |
0.198 |
0.84 |
0.64–1.1 |
| ypN categorya |
<0.001 |
|
|
| ypN0 | <0.001 | 0.43 | 0.32–0.59 |
| ypN1 | 0.003 | 0.61 | 0.44–0.85 |
| ypN2 |
0.002 |
0.63 |
0.47–0.84 |
| M categorya |
<0.001 |
0.55 |
0.42–0.72 |
| R categorya |
0.006 |
|
|
| R0 | 0.011 | 0.53 | 0.33–0.86 |
| R1 |
0.212 |
0.74 |
0.46–1.19 |
|
(D) (R0 completely resected patients) (included: grading, Laurén classification, signet ring cell cancer, clinical response, complications, surgical complications, ypTNM, and histopathological regression) | |||
| Surgical complicationsa |
0.004 |
0.68 |
0.52–0.89 |
| ypT categorya |
<0.001 |
|
|
| ypT0 | 0.002 | 0.25 | 0.10–0.61 |
| ypT1 | 0.011 | 0.40 | 0.19–0.81 |
| ypT2 | <0.001 | 0.36 | 0.21–0.63 |
| ypT3 |
0.318 |
0.922 |
0.56–1.21 |
| ypN categorya |
<0.001 |
|
|
| ypN0 | <0.001 | 0.39 | 0.27–0.57 |
| ypN1 | 0.006 | 0.58 | 0.39–0.85 |
| ypN2 |
0.006 |
0.59 |
0.41–0.86 |
| M category a | <0.001 | 0.47 | 0.33–0.67 |
Abbreviations: CI=confidence interval; RR=relative risk.
Confirmation by Cox backward regression analysis.
Results of Cox forward regression analysis.